DR LAL PATHLABS
Back to Cashflow Statement
|
DR LAL PATHLABS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-414 Cr | ₹-283 Cr | ₹136 Cr | ₹-139 Cr | ₹-190 Cr |
What is the latest Cash Flow from Financing Activities ratio of DR LAL PATHLABS ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-414 Cr |
Mar2023 | ₹-283 Cr |
Mar2022 | ₹136 Cr |
Mar2021 | ₹-139 Cr |
Mar2020 | ₹-190 Cr |
How is Cash Flow from Financing Activities of DR LAL PATHLABS Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-414 Cr | Negative | |
Mar2023 | ₹-283 Cr | Negative | |
Mar2022 | ₹136 Cr | Positive | |
Mar2021 | ₹-139 Cr | Negative | |
Mar2020 | ₹-190 Cr | - |
Compare Cash Flow from Financing Activities of peers of DR LAL PATHLABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DR LAL PATHLABS | ₹25,354.2 Cr | 0.2% | -3.3% | 15% | Stock Analytics | |
APOLLO HOSPITALS ENTERPRISE | ₹100,347.0 Cr | 3.5% | 0.6% | 27.9% | Stock Analytics | |
MAX HEALTHCARE INSTITUTE | ₹97,859.7 Cr | 1.7% | 7.3% | 59.9% | Stock Analytics | |
FORTIS HEALTHCARE | ₹48,721.2 Cr | -5.2% | 10.6% | 81.8% | Stock Analytics | |
GLOBAL HEALTH | ₹28,920.2 Cr | 0.4% | 1.5% | 23.1% | Stock Analytics | |
NARAYANA HRUDAYALAYA | ₹25,800.6 Cr | 0.3% | 2.1% | 1.4% | Stock Analytics |
DR LAL PATHLABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR LAL PATHLABS | 0.2% |
-3.3% |
15% |
SENSEX | 3.4% |
0.2% |
21.7% |
You may also like the below Video Courses